Presurgical octreotide treatment in acromegaly
- 1 September 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (9) , 51-58
- https://doi.org/10.1016/0026-0495(92)90031-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Preoperative Treatment of Acromegaly with Long-Acting Somatostatin Analog SMS 201-995: Shrinkage of Invasive Pituitary Macroadenomas and Improved Surgical Remission Rate*Journal of Clinical Endocrinology & Metabolism, 1988
- Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patientsJournal of Neurosurgery, 1988
- Treatment of Resistant Acromegaly with a Long-Acting Somatostatin Analogue (SMS 201-995)Annals of Internal Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Acromegaly: Biochemical Assessment of Cure after Long Term Follow-Up of Transsphenoidal Selective Adenomectomy*Journal of Clinical Endocrinology & Metabolism, 1985
- Transsphenoidal surgery for acromegaly—long-term results in 100 patientsSurgical Neurology, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effect of Somatostatin in Patients with AcromegalyNew England Journal of Medicine, 1974
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974